Evidence map›Paper›PMID 39628692›Full record

ArticleInternational journal of medical sciences2024

Co-inhibition of PGF and VEGFA enhances the effectiveness of immunotherapy in bladder cancer.

Xianzhi Yang, Haoxiang Zheng, Jianxu Huang, Yujun Liu, Yingrui Li, Bingwen Zhang, Chu Sun, Yuqing Li, Jean Paul Thiery, Song Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xianzhi YangInstitute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China.
Haoxiang ZhengInstitute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China.
Jianxu HuangShantou University Medical College, Shantou University, Shantou, China.
Yujun LiuMedical School, Anhui University of Science and Technology, Huainan 232001, China.
Yingrui LiInstitute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China.
Bingwen ZhangGuangzhou Laboratory, Guangzhou International BioIsland, Guangzhou 510005, China.
Chu SunGuangzhou Laboratory, Guangzhou International BioIsland, Guangzhou 510005, China.
Yuqing LiDepartment of Urology, South China Hospital of Shenzhen University, Shenzhen 518116, China.
Jean Paul ThieryGuangzhou Laboratory, Guangzhou International BioIsland, Guangzhou 510005, China.
Song WuDepartment of Urology, South China Hospital of Shenzhen University, Shenzhen 518116, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immune Checkpoint InhibitorsNeovascularization, PathologicPlacenta Growth FactorUrinary Bladder NeoplasmsVascular Endothelial Growth Factor AAngiogenesis InhibitorsAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansHuman Umbilical Vein Endothelial CellsImmunotherapyMiceProgrammed Cell Death 1 ReceptorXenograft Model Antitumor AssaysAngiogenesis InhibitorsImmune Checkpoint InhibitorsPDCD1 protein, humanPGF protein, humanPlacenta Growth FactorProgrammed Cell Death 1 ReceptorVascular Endothelial Growth Factor AVEGFA protein, humananti-angiogenesisanti-PD1bladder cancerPGF

Identifiers

PMID39628692
PMCPMC11610333

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.